The role of dose density in combination cancer chemotherapy

Autor(es)

Lopez, Alvaro G. ^[1] ; Iarosz, Kelly C. ^[2] ; Batist, Antonio M. ^[3] ; Seoane, Jesus M. ^[1] ; Viana, Ricardo L. ^[4] ; Sanjuan, Miguel A. F. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Rey Juan Carlos, Dept Fis, Madrid - Spain

^[2] Univ Sao Paulo, Inst Phys, Sao Paulo, SP - Brazil

^[3] Univ Estadual Ponta Grossa, Dept Math & Stat, Ponta Grossa, PR - Brazil

^[4] Univ Fed Parana, Dept Phys, Curitiba, Parana - Brazil

• Tipo de documento: Artigo Científico
• Fonte: COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION; v. 79, DEC 2019.
• Citações Web of Science: 0

Resumo

A multicompartment mathematical model is presented with the goal of studying the role of dose-dense protocols in the context of combination cancer chemotherapy. Dose-dense protocols are intended to reduce the period between courses of chemotherapy from three to two weeks or less, in order to avoid the regrowth of the tumor during the meantime and achieve maximum cell kill at the end of the treatment. Inspired by clinical trials, we carry out a randomized computational study to systematically compare a variety of protocols using two drugs of different specificity. Our results suggest that cycle specific drugs can be administered at low doses between courses of treatment to arrest the relapse of the tumor. This might be a better strategy than reducing the period between cycles. (C) 2019 Elsevier B.V. All rights reserved. (AU)

• Processo FAPESP: 18/03211-6 - Dinâmica não linear
• Beneficiário: Iberê Luiz Caldas
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 15/07311-7 - Comportamento dinâmico de redes neurais
• Beneficiário: Kelly Cristiane Iarosz
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado